Filters: Keyword is Antiretroviral Therapy, Highly Active [Clear All Filters]
"Incidence of non-AIDS-defining malignancies in HIV-infected versus noninfected patients in the HAART era: impact of immunosuppression." Journal of acquired immune deficiency syndromes (1999) 52, no. 2 (2009): 203-8. Abstract
"Incidence of Tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 41, no. 12 (2005): 1772-82. Abstract
"Increased Black-White disparities in mortality after the introduction of lifesaving innovations: a possible consequence of US federal laws." American journal of public health 100, no. 11 (2010): 2176-84. Abstract
"Increased COPD among HIV-positive compared to HIV-negative veterans." Chest 130, no. 5 (2006): 1326-33. Abstract
"Increased microbial translocation in ≤ 180 days old perinatally human immunodeficiency virus-positive infants as compared with human immunodeficiency virus-exposed uninfected infants of similar age." The Pediatric infectious disease journal 30, no. 10 (2011): 877-82. Abstract
"Increasing drug users' adherence to HIV treatment: results of a peer-driven intervention feasibility study." Social science & medicine (1982) 55, no. 2 (2002): 235-46. Abstract
"The information-motivation-behavioral skills model of antiretroviral adherence and its applications." Current HIV/AIDS reports 5, no. 4 (2008): 193-203. Abstract
"Initial strategies for integrating buprenorphine into HIV care settings in the United States." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 43 Suppl 4 (2006): S191-6. Abstract
"Initiation, adherence, and retention in a randomized controlled trial of directly administered antiretroviral therapy." AIDS and behavior 12, no. 2 (2008): 284-93. Abstract
"Is antiretroviral therapy cost-effective in South Africa?" PLoS medicine 3, no. 1 (2006): e60.
"Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies." Lancet 372, no. 9635 (2008): 293-9. Abstract
"Lifetime cost of HIV care in France during the era of highly active antiretroviral therapy." Antiviral therapy 7, no. 4 (2002): 257-66. Abstract
"Long-term HIV/AIDS survival estimation in the highly active antiretroviral therapy era." Medical decision making : an international journal of the Society for Medical Decision Making 23, no. 1 (2003): 9-20. Abstract
"Managing HIV/AIDS in correctional settings." Current HIV/AIDS reports 2, no. 4 (2005): 165-70. Abstract
"Medication persistence of HIV-infected drug users on directly administered antiretroviral therapy." AIDS and behavior 17, no. 1 (2013): 113-21. Abstract
"Medication-assisted treatment and HIV/AIDS: aspects in treating HIV-infected drug users." AIDS (London, England) 24, no. 3 (2010): 331-40. Abstract
"Models for integrating buprenorphine therapy into the primary HIV care setting." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 42, no. 5 (2006): 716-21. Abstract
"Monitoring of long-term toxicities of HIV treatments: an international perspective." AIDS (London, England) 17, no. 17 (2003): 2407-17.
"Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studies." PLoS medicine 11, no. 9 (2014): e1001718. Abstract
"Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries." International journal of epidemiology 38, no. 6 (2009): 1624-33. Abstract
"Multidrug-resistant and extensively drug-resistant tuberculosis: implications for the HIV epidemic and antiretroviral therapy rollout in South Africa." The Journal of infectious diseases 196 Suppl 3 (2007): S482-90. Abstract
"A national study of the relationship of care site HIV specialization to early adoption of highly active antiretroviral therapy." Medical care 43, no. 1 (2005): 12-20. Abstract
"Neurocognitive impairment and HIV risk factors: a reciprocal relationship." AIDS and behavior 14, no. 6 (2010): 1213-26. Abstract
"The next therapeutic challenge in HIV: polypharmacy." Drugs & aging 30, no. 8 (2013): 613-28. Abstract
"Participant characteristics and HIV risk behaviors among individuals entering integrated buprenorphine/naloxone and HIV care." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S14-21. Abstract
"Physician specialization and antiretroviral therapy for HIV." Journal of general internal medicine 18, no. 4 (2003): 233-41. Abstract
"Physician specialization and the quality of care for human immunodeficiency virus infection." Archives of internal medicine 165, no. 10 (2005): 1133-9. Abstract
"A pilot study of once-daily antiretroviral therapy integrated with tuberculosis directly observed therapy in a resource-limited setting." Journal of acquired immune deficiency syndromes (1999) 36, no. 4 (2004): 929-34. Abstract
"Pilot study to enhance HIV care using needle exchange-based health services for out-of-treatment injecting drug users." Journal of urban health : bulletin of the New York Academy of Medicine 80, no. 3 (2003): 416-27. Abstract
"Prevalence and pattern of disclosure of HIV status in HIV-infected children in Ghana." AIDS and behavior 15, no. 6 (2011): 1121-7. Abstract
"Prioritizing primary care in HIV: comorbidity, toxicity, and demography." Topics in HIV medicine : a publication of the International AIDS Society, USA 14, no. 5 (2006): 159-63. Abstract
"Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies." Lancet 360, no. 9327 (2002): 119-29. Abstract
"Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies." AIDS (London, England) 21, no. 9 (2007): 1185-97. Abstract
"Prognostic importance of anaemia in HIV type-1-infected patients starting antiretroviral therapy: collaborative analysis of prospective cohort studies." Antiviral therapy 13, no. 8 (2008): 959-67. Abstract
"Projecting the cost-effectiveness of adherence interventions in persons with human immunodeficiency virus infection." The American journal of medicine 115, no. 8 (2003): 632-41. Abstract
"The quality of care received by HIV patients without a primary provider." AIDS care 20, no. 1 (2008): 35-42. Abstract
"Racial and sex disparities in life expectancy losses among HIV-infected persons in the united states: impact of risk behavior, late initiation, and early discontinuation of antiretroviral therapy." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 49, no. 10 (2009): 1570-8. Abstract
"Racial/Ethnic disparities in ART adherence in the United States: findings from the MACH14 study." Journal of acquired immune deficiency syndromes (1999) 60, no. 5 (2012): 466-72. Abstract
"A randomized comparison of two instruments for measuring self-reported antiretroviral adherence." AIDS care 20, no. 2 (2008): 161-9. Abstract
"A randomized controlled trial of highly active antiretroviral therapy versus highly active antiretroviral therapy and chemotherapy in therapy-naive patients with HIV-associated Kaposi sarcoma in South Africa." Journal of acquired immune deficiency syndromes (1999) 60, no. 2 (2012): 150-7. Abstract
"Randomized, controlled trials of directly administered antiretroviral therapy for HIV-infected patients: questions about study population and analytical approach." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 43, no. 9 (2006): 1221-2; author reply 1222-3.
"Resource utilization and cost-effectiveness of counselor- vs. provider-based rapid point-of-care HIV screening in the emergency department." PloS one 6, no. 10 (2011): e25575. Abstract
"Risk factors for tuberculosis after highly active antiretroviral therapy initiation in the United States and Canada: implications for tuberculosis screening." The Journal of infectious diseases 204, no. 6 (2011): 893-901. Abstract
"Risk of diabetes in HIV infected veterans pre- and post-HAART and the role of HCV coinfection." Hepatology (Baltimore, Md.) 40, no. 1 (2004): 115-9. Abstract
"Scaling up antiretroviral therapy in South Africa: the impact of speed on survival." The Journal of infectious diseases 197, no. 9 (2008): 1324-32. Abstract
"Strategies for Preventing HIV Transmission." JAMA : the journal of the American Medical Association 302, no. 14 (2009): 1531; author reply 1531-2.
"Superiority of directly administered antiretroviral therapy over self-administered therapy among HIV-infected drug users: a prospective, randomized, controlled trial." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 45, no. 6 (2007): 770-8. Abstract
"The survival benefits of antiretroviral therapy in South Africa." The Journal of infectious diseases 209, no. 4 (2014): 491-9. Abstract
"Survival from XDR-TB is associated with modifiable clinical characteristics in rural South Africa." PloS one 7, no. 3 (2012): e31786. Abstract
